Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Mycobacterium tuberculosis-Induced Bronchoalveolar Lavage Gene Expression Signature in Latent Tuberculosis Infection Is Dominated by Pleiotropic Effects of CD4+ T Cell-Dependent IFN-γ Production despite the Presence of Polyfunctional T Cells within the Airways.

Jarvela J, Moyer M, Leahy P, Bonfield T, Fletcher D, Mkono WN, Aung H, Canaday DH, Dazard JE, Silver RF.

J Immunol. 2019 Oct 15;203(8):2194-2209. doi: 10.4049/jimmunol.1900230. Epub 2019 Sep 20.

PMID:
31541022
2.

Diversity of Human and Macaque Airway Immune Cells at Baseline and during Tuberculosis Infection.

Silver RF, Myers AJ, Jarvela J, Flynn J, Rutledge T, Bonfield T, Lin PL.

Am J Respir Cell Mol Biol. 2016 Dec;55(6):899-908.

3.

Pulmonary responses to pathogen-specific antigens in latent Mycobacterium tuberculosis infection.

Jarvela JR, Tuscano L, Lee H, Silver RF.

Tuberculosis (Edinb). 2016 Jan;96:158-64. doi: 10.1016/j.tube.2015.10.006. Epub 2015 Dec 8.

4.

Proteomic and bioinformatics profile of paired human alveolar macrophages and peripheral blood monocytes.

Tomechko SE, Lundberg KC, Jarvela J, Bebek G, Chesnokov NG, Schlatzer D, Ewing RM, Boom WH, Chance MR, Silver RF.

Proteomics. 2015 Nov;15(22):3797-805. doi: 10.1002/pmic.201400496.

5.

Role of protease inhibitor 9 in survival and replication of Mycobacterium tuberculosis in mononuclear phagocytes from HIV-1-infected patients.

Toossi Z, Wu M, Liu S, Hirsch CS, Walrath J, van Ham M, Silver RF.

AIDS. 2014 Mar 13;28(5):679-87. doi: 10.1097/QAD.0000000000000192.

6.

Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG.

Fletcher HA, Tanner R, Wallis RS, Meyer J, Manjaly ZR, Harris S, Satti I, Silver RF, Hoft D, Kampmann B, Walker KB, Dockrell HM, Fruth U, Barker L, Brennan MJ, McShane H.

Clin Vaccine Immunol. 2013 Nov;20(11):1683-9. doi: 10.1128/CVI.00427-13. Epub 2013 Aug 28.

7.

Disordered Toll-like receptor 2 responses in the pathogenesis of pulmonary sarcoidosis.

Gabrilovich MI, Walrath J, van Lunteren J, Nethery D, Seifu M, Kern JA, Harding CV, Tuscano L, Lee H, Williams SD, Mackay W, Tomashefski JF Jr, Silver RF.

Clin Exp Immunol. 2013 Sep;173(3):512-22. doi: 10.1111/cei.12138.

8.

Dipterinyl calcium pentahydrate inhibits intracellular mycobacterial growth in human monocytes via the C-C chemokine MIP-1β and nitric oxide.

Sakala IG, Eickhoff CS, Blazevic A, Moheno P, Silver RF, Hoft DF.

Infect Immun. 2013 Jun;81(6):1974-83. doi: 10.1128/IAI.01393-12. Epub 2013 Mar 18.

9.

Induction of serine protease inhibitor 9 by Mycobacterium tuberculosis inhibits apoptosis and promotes survival of infected macrophages.

Toossi Z, Wu M, Rojas R, Kalsdorf B, Aung H, Hirsch CS, Walrath J, Wolbink A, van Ham M, Silver RF.

J Infect Dis. 2012 Jan 1;205(1):144-51. doi: 10.1093/infdis/jir697. Epub 2011 Nov 16.

10.

Neuregulin-1-human epidermal receptor-2 signaling is a central regulator of pulmonary epithelial permeability and acute lung injury.

Finigan JH, Faress JA, Wilkinson E, Mishra RS, Nethery DE, Wyler D, Shatat M, Ware LB, Matthay MA, Mason R, Silver RF, Kern JA.

J Biol Chem. 2011 Mar 25;286(12):10660-70. doi: 10.1074/jbc.M110.208041. Epub 2011 Jan 19.

11.

The α4β1 integrin in localization of Mycobacterium tuberculosis-specific T helper type 1 cells to the human lung.

Walrath JR, Silver RF.

Am J Respir Cell Mol Biol. 2011 Jul;45(1):24-30. doi: 10.1165/rcmb.2010-0241OC. Epub 2010 Aug 19.

PMID:
20724551
12.

Human alveolar macrophage gene responses to Mycobacterium tuberculosis strains H37Ra and H37Rv.

Silver RF, Walrath J, Lee H, Jacobson BA, Horton H, Bowman MR, Nocka K, Sypek JP.

Am J Respir Cell Mol Biol. 2009 Apr;40(4):491-504. doi: 10.1165/rcmb.2008-0219OC. Epub 2008 Sep 11.

13.

Beijing family Mycobacterium tuberculosis strains differ in their intracellular growth in THP-1 macrophages.

Theus S, Eisenach K, Fomukong N, Silver RF, Cave MD.

Int J Tuberc Lung Dis. 2007 Oct;11(10):1087-93.

PMID:
17945065
14.

Differences in the growth of paired Ugandan isolates of Mycobacterium tuberculosis within human mononuclear phagocytes correlate with epidemiological evidence of strain virulence.

Theus SA, Cave MD, Eisenach K, Walrath J, Lee H, Mackay W, Whalen C, Silver RF.

Infect Immun. 2006 Dec;74(12):6865-76. Epub 2006 Sep 18.

15.

Resident Th1-like effector memory cells in pulmonary recall responses to Mycobacterium tuberculosis.

Walrath J, Zukowski L, Krywiak A, Silver RF.

Am J Respir Cell Mol Biol. 2005 Jul;33(1):48-55. Epub 2005 Mar 18.

16.

Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis.

Song Z, Marzilli L, Greenlee BM, Chen ES, Silver RF, Askin FB, Teirstein AS, Zhang Y, Cotter RJ, Moller DR.

J Exp Med. 2005 Mar 7;201(5):755-67. Erratum in: J Exp Med. 2005 Sep 5;202(5):721.

17.

Disruption of response regulator gene, devR, leads to attenuation in virulence of Mycobacterium tuberculosis.

Malhotra V, Sharma D, Ramanathan VD, Shakila H, Saini DK, Chakravorty S, Das TK, Li Q, Silver RF, Narayanan PR, Tyagi JS.

FEMS Microbiol Lett. 2004 Feb 16;231(2):237-45.

18.

Recruitment of antigen-specific Th1-like responses to the human lung following bronchoscopic segmental challenge with purified protein derivative of Mycobacterium tuberculosis.

Silver RF, Zukowski L, Kotake S, Li Q, Pozuelo F, Krywiak A, Larkin R.

Am J Respir Cell Mol Biol. 2003 Jul;29(1):117-23.

PMID:
12821447
19.

Investigation of the relationships between immune-mediated inhibition of mycobacterial growth and other potential surrogate markers of protective Mycobacterium tuberculosis immunity.

Hoft DF, Worku S, Kampmann B, Whalen CC, Ellner JJ, Hirsch CS, Brown RB, Larkin R, Li Q, Yun H, Silver RF.

J Infect Dis. 2002 Nov 15;186(10):1448-57. Epub 2002 Oct 23.

PMID:
12404160
20.

Differences in rate and variability of intracellular growth of a panel of Mycobacterium tuberculosis clinical isolates within a human monocyte model.

Li Q, Whalen CC, Albert JM, Larkin R, Zukowski L, Cave MD, Silver RF.

Infect Immun. 2002 Nov;70(11):6489-93.

21.

ATP and control of intracellular growth of mycobacteria by T cells.

Canaday DH, Beigi R, Silver RF, Harding CV, Boom WH, Dubyak GR.

Infect Immun. 2002 Nov;70(11):6456-9.

22.

CD40 ligand (CD154) does not contribute to lymphocyte-mediated inhibition of virulent Mycobacterium tuberculosis within human monocytes.

Larkin R, Benjamin CD, Hsu YM, Li Q, Zukowski L, Silver RF.

Infect Immun. 2002 Aug;70(8):4716-20.

23.

Bactericidal activity in whole blood as a potential surrogate marker of immunity after vaccination against tuberculosis.

Cheon SH, Kampmann B, Hise AG, Phillips M, Song HY, Landen K, Li Q, Larkin R, Ellner JJ, Silver RF, Hoft DF, Wallis RS.

Clin Diagn Lab Immunol. 2002 Jul;9(4):901-7.

24.

CD4(+) and CD8(+) T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism.

Canaday DH, Wilkinson RJ, Li Q, Harding CV, Silver RF, Boom WH.

J Immunol. 2001 Sep 1;167(5):2734-42.

25.

Human natural killer cells mediate killing of intracellular Mycobacterium tuberculosis H37Rv via granule-independent mechanisms.

Brill KJ, Li Q, Larkin R, Canaday DH, Kaplan DR, Boom WH, Silver RF.

Infect Immun. 2001 Mar;69(3):1755-65.

26.
31.

Selection of oligoclonal V beta-specific T cells in the intradermal response to Kveim-Siltzbach reagent in individuals with sarcoidosis.

Klein JT, Horn TD, Forman JD, Silver RF, Teirstein AS, Moller DR.

J Immunol. 1995 Feb 1;154(3):1450-60.

PMID:
7822810
32.

Selective activation and accumulation of oligoclonal V beta-specific T cells in active pulmonary sarcoidosis.

Forman JD, Klein JT, Silver RF, Liu MC, Greenlee BM, Moller DR.

J Clin Invest. 1994 Oct;94(4):1533-42.

33.

T cell receptor variable beta-gene expression in the normal lung and in active pulmonary sarcoidosis.

Forman JD, Silver RF, Klein JT, Britt EJ, Scott PP, Schonfeld SA, Johns CJ, Moller DR.

Chest. 1993 Feb;103(2 Suppl):78S. No abstract available.

PMID:
8428545
34.

Evidence for the mode of chemical action of 1,4-naphthoquinones in bacteriostasis.

Holmes HL, Currie DJ, Maltman JR, Silver RF, Lough CE, Leahy GJ.

Chemotherapia (Basel). 1964-1965;9(4):241-7. No abstract available.

PMID:
5831222

Supplemental Content

Loading ...
Support Center